These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 4216898)
1. [Effect of rifampicin on the intra- and extracellularly located Mycobacterium tuberculosis]. Pavlov EP; Tushov EG; Kotliarov LM Probl Tuberk; 1974; (12):64-7. PubMed ID: 4216898 [No Abstract] [Full Text] [Related]
2. [Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse]. Grosset J; Truffot-Pernot C; Poggi S; Lecoeur H; Chastang C Rev Mal Respir; 1985; 2(4):205-8. PubMed ID: 3937188 [TBL] [Abstract][Full Text] [Related]
3. [In vitro experiment showing that chemotherapy of tuberculosis by aminoglycoside antibiotics may influence successive chemotherapy with rifampicin]. Tsukamura M Kekkaku; 1991 Jan; 66(1):13-8. PubMed ID: 1901613 [TBL] [Abstract][Full Text] [Related]
4. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin]. Makarevich NM; Mkrtchian SV; Afanas'eva IuP Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321 [No Abstract] [Full Text] [Related]
5. [Criteria of resistance of some antibiotics and chemotherapeutics for strains of Mycobacterium tuberculosis isolated in Czechoslovakia. Cycloserin, ethionamide, pyrazinamide, rifampicin, and ethambutol (author's transl)]. Víznerová A Cas Lek Cesk; 1979 Feb; 118(8):240-5. PubMed ID: 109213 [No Abstract] [Full Text] [Related]
9. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs]. Nagata A; Mase M; Yamamoto M; Nakamura H Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767 [No Abstract] [Full Text] [Related]
10. [Drug sensitivity of the so-called atypical mycobacteria]. Lucchesi M; Mancini P; Matzeu M Ann Ist Carlo Forlanini; 1968; 28(1):25-41. PubMed ID: 4314838 [No Abstract] [Full Text] [Related]
11. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898 [TBL] [Abstract][Full Text] [Related]
12. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin. McClatchy JK; Kanes W; Davidson PT; Moulding TS Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613 [TBL] [Abstract][Full Text] [Related]
14. [Effect on Mycobacterium tuberculosis of rifamycin SV alone and combined with major bacillostatic agents]. Coletsos PJ Rev Tuberc Pneumol (Paris); 1967; 31(1):17-30. PubMed ID: 4962522 [No Abstract] [Full Text] [Related]
15. Mycobacterium resistance to antimycobacterial reagent. Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L Therapie; 1999; 54(5):623-5. PubMed ID: 10667100 [TBL] [Abstract][Full Text] [Related]
16. [Factors affecting the activity of streptomycin, kanamycin and isoniazid in relation to intracellular Mycobacterium tuberculosis]. Pavlov EP Probl Tuberk; 1970; 48(9):72-6. PubMed ID: 4996496 [No Abstract] [Full Text] [Related]
17. [Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate]. Yamazaki T; Sato N; Yamashita K; Okazawa Y; Miyao H; Tanno K Rinsho Byori; 1999 Feb; 47(2):170-5. PubMed ID: 10097635 [TBL] [Abstract][Full Text] [Related]
18. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro]. Ota Y Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204 [No Abstract] [Full Text] [Related]
19. [Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent]. Shaĭkhaev AIa; Naumov VN Probl Tuberk; 2000; (4):24-6. PubMed ID: 10981427 [TBL] [Abstract][Full Text] [Related]
20. [Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients]. Endo K Jpn J Antibiot; 1970 Aug; 23(4):387-9. PubMed ID: 4321638 [No Abstract] [Full Text] [Related] [Next] [New Search]